Heritage Global Partners, Federal Equipment Company, Capital Recovery Group, and PPL Group to Jointly Manage Largest North American Pharmaceutical Manufacturing Asset Auctions in 2016
Series of Global Online Sales Featuring over 1,000 Lots of Former Sanofi Pharmaceutical Assets from 692,000 sq. ft. Capsule Manufacturing Plant Begins September 26
September 07, 2016 10:26 AM Eastern Daylight Time
SAN DIEGO & KANSAS CITY, Mo.–(BUSINESS WIRE)–Heritage Global Partners (“HGP”), Federal Equipment Company (“FEC”), Capital Recovery Group (“CRG”) and PPL Group (“PPL”), today announced they will jointly manage a series of upcoming worldwide online sales featuring the former pharmaceutical manufacturing assets of Sanofi beginning September 26, 2016.
The sales, which will be conducted exclusively via online auction or by Private Treaty, cover the complete removal of assets from the former capsule manufacturing plant at 10236 Marion Park Dr., Kansas City, Missouri. Over 1,000 lots of pharmaceutical manufacturing machinery and lab equipment are available for purchase.
“The sales present a tremendous opportunity for bidders to acquire large quantities of high-quality solid dose and liquid production machinery and well-maintained lab equipment at attractive prices”
|Former Sanofi Pharmaceutical Manufacturing Plant Assets|
September 26 (7 am CT) – September 28 (11 am CT)
December 13 (7 am CT) – December 15 (12 pm CT)
Note: HGP is considering pre-auction offers on the processing and packaging assets
The facility will be made available to parties interested in inspecting the equipment, preparing an offer, or bidding at auction. To arrange a preview, please contact Nick Dove (information below).
Adam Covitt, FEC VP, stated, “We are conducting the year’s largest sale of pharmaceutical assets in North America and anticipate strong demand from buyers worldwide for our selection of late-model manufacturing, processing and support assets from leading brands.”
“The sales present a tremendous opportunity for bidders to acquire large quantities of high-quality solid dose and liquid production machinery and well-maintained lab equipment at attractive prices,” noted Bill Firestone, CRG President.
David Muslin, PPL CEO, added, “We are pleased to assist in remarketing this unprecedented offering of well-maintained pharmaceutical assets and are confident buyers across the globe will act quickly to secure lots of high-grade machinery and equipment to support their current production facilities.”